The leading CEO forum for pharmaceutical producers, distributors and retailers in Russia

24 - 25 November 2020

Elena Kartasheva, President, Takeda
Elena Kartasheva

President

Takeda

Matthias Wernicke, Managing Director, Russia and CIS, Merck
Matthias Wernicke

Managing Director, Russia and CIS

Merck

Ugur Gunaydin, General Director, Russia & CIS, Amgen
Ugur Gunaydin

General Director, Russia & CIS

Amgen

Irina Zaporozhets,  General Manager, Russia & CIS, Eli Lilly & Company
Irina Zaporozhets

General Manager, Russia & CIS

Eli Lilly & Company

Inna Bakumenko, General Manager Russia and CIS, Abbott
Inna Bakumenko

General Manager Russia and CIS

Abbott

Marek Vasicek, General Manager, Russia, Bristol Myers Squibb
Marek Vasicek

General Manager, Russia

Bristol Myers Squibb

Stephan Eder, Executive Vice President, Russia and CIS, STADA
Stephan Eder

Executive Vice President, Russia and CIS

STADA

Elena Litvinova, General Director, NovaMedica
Elena Litvinova

General Director

NovaMedica

Peter Rodionov, General Manager, Geropharm
Peter Rodionov

General Manager

Geropharm

Maxim Stetsyuk, Executive Director, member of the Management Board, Nanolek
Maxim Stetsyuk

Executive Director, member of the Management Board

Nanolek

Adlane Soudani, General Manager, Ipsen
Adlane Soudani

General Manager

Ipsen

Vasily Ignatiev, General Director, R-Pharm
Vasily Ignatiev

General Director

R-Pharm

Frederic Jumel, General Manager, Sanofi Pasteur
Frederic Jumel

General Manager

Sanofi Pasteur

Ivan Poljak, General Manager, Abbott’s Veropharm
Ivan Poljak

General Manager

Abbott’s Veropharm

Anastasia Karpova, General Director, Erkafarm
Anastasia Karpova

General Director

Erkafarm

Valentina Buchneva, Head of Region Eurasia, Bosnalijek
Valentina Buchneva

Head of Region Eurasia

Bosnalijek

Alexander Filippov, General Director, Rigla
Alexander Filippov

General Director

Rigla

Dmitry Pogrebinsky, General Director, Protek
Dmitry Pogrebinsky

General Director

Protek

Alexander Kuzin, General Director, Pharmacy Chain 36.6
Alexander Kuzin

General Director

Pharmacy Chain 36.6

Evgeniy Nifantyev, General Director, Retail Chain “Neopharm”
Evgeniy Nifantyev

General Director

Retail Chain “Neopharm”

Alexander Bykov, Director of Healthcare Economics, R-Pharm
Alexander Bykov

Director of Healthcare Economics

R-Pharm

Yury Krestinskiy, Chairman of the Expert Board, Institute of Public Healthcare Development
Yury Krestinskiy

Chairman of the Expert Board

Institute of Public Healthcare Development

Alexandr Sokolov, Key Account Director, Teva
Alexandr Sokolov

Key Account Director

Teva

Elena Nevolina, Executive Director, National Pharmaceutical Chamber
Elena Nevolina

Executive Director

National Pharmaceutical Chamber

Lilia Titova, Executive Director, The Union of Professional Pharmaceutical Organizations (SPFO)
Lilia Titova

Executive Director

The Union of Professional Pharmaceutical Organizations (SPFO)

Igor Bakhmetiev, Commercial Director, Russia and CIS, STADA
Igor Bakhmetiev

Commercial Director, Russia and CIS

STADA

Ilya Afanasov, Head of PMO & BD&L, Cluster Russia, Ukraine & CIS, Consumer Health, Bayer
Ilya Afanasov

Head of PMO & BD&L, Cluster Russia, Ukraine & CIS, Consumer Health

Bayer

David Pérez Godia, Supply Chain Manager, Russia & CIS, Merck
David Pérez Godia

Supply Chain Manager, Russia & CIS

Merck

Oxana Kudelya, Market Access, Pricing and Commercial Director, Russia & CIS, Merck
Oxana Kudelya

Market Access, Pricing and Commercial Director, Russia & CIS

Merck

Anastasia Tatarnikova, Chairman, Home for Rares
Anastasia Tatarnikova

Chairman

Home for Rares

Alisa Dzhangiryants, Director, MA & Pricing Department, Bristol Myers Squibb
Alisa Dzhangiryants

Director, MA & Pricing Department

Bristol Myers Squibb

Larisa Popovich, Director, Institute for Health Economics, Higher School of Economics
Larisa Popovich

Director, Institute for Health Economics

Higher School of Economics

Vitaly Dembrovskiy, Market Access Director, Russia and Eurasia, AstraZeneca
Vitaly Dembrovskiy

Market Access Director, Russia and Eurasia

AstraZeneca

Vilena Galkina, Government Affairs Director, Geropharm
Vilena Galkina

Government Affairs Director

Geropharm

Marina Rykova, Marketing Director, Geropharm
Marina Rykova

Marketing Director

Geropharm

Rustam Iksanov, Vice President, R&D, NovaMedica
Rustam Iksanov

Vice President, R&D

NovaMedica

Yuriy Mochalin, Director of Corporate Communications, Eurasia, Sanofi
Yuriy Mochalin

Director of Corporate Communications, Eurasia

Sanofi

Andrey Kolesnikov, Senior Director Government Affairs & Market Access, Russia and Eurasia , Teva
Andrey Kolesnikov

Senior Director Government Affairs & Market Access, Russia and Eurasia

Teva

Anna Konstantinova, Digital Client Partner, Pfizer
Anna Konstantinova

Digital Client Partner

Pfizer

Alexey Migulin, Market Access Director, Russia and Belarus, Pfizer
Alexey Migulin

Market Access Director, Russia and Belarus

Pfizer

Artyom Selyanskiy, Head of Track & Trace, Russia and CIS, STADA
Artyom Selyanskiy

Head of Track & Trace, Russia and CIS

STADA

Maria Lituchaya, General Manager, Russia & CIS, CSL Behring
Maria Lituchaya

General Manager, Russia & CIS

CSL Behring

Alexander Evstashenkov, Head of Expert Consulting Centre, Institute of Public Procurement
Alexander Evstashenkov

Head of Expert Consulting Centre

Institute of Public Procurement

Viktor Trukhin, Director, St. Petersburg Research Institute of Vaccines and Serums of the FMBA of Russia
Viktor Trukhin

Director

St. Petersburg Research Institute of Vaccines and Serums of the FMBA of Russia

Irina Romanova, Head of Consumer Healthcare in Eurasia zone, Sanofi
Irina Romanova

Head of Consumer Healthcare in Eurasia zone

Sanofi

Anastasia Altaychinova, National Sales Manager, Consumer Healthcare, Sanofi
Anastasia Altaychinova

National Sales Manager, Consumer Healthcare

Sanofi

Kirill Danishevskiy, Market Access Director, Takeda
Kirill Danishevskiy

Market Access Director

Takeda

Natalia Lazareva, MD, Professor, Clinical pharmacology department, Sechenov University
Natalia Lazareva

MD, Professor, Clinical pharmacology department

Sechenov University

Dmitry Vlasov, Medical Director Russia, Head Medical Cluster CIS, Bayer
Dmitry Vlasov

Medical Director Russia, Head Medical Cluster CIS

Bayer

Alexei Shavenzov, GA&P Senior Director Russia & CIS, Johnson & Johnson
Alexei Shavenzov

GA&P Senior Director Russia & CIS

Johnson & Johnson

Jurate Svarcaite, Director General, Association of the European Self-Care Industry (AESGP)
Jurate Svarcaite

Director General

Association of the European Self-Care Industry (AESGP)

Alexander Rudko, General Director, R&D-centre NovaMedica Innotech
Alexander Rudko

General Director

R&D-centre NovaMedica Innotech

Svyatoslav Plavinsky, Professor, North-western State Medical University named after I.I. Mechnikov
Svyatoslav Plavinsky

Professor

North-western State Medical University named after I.I. Mechnikov

Yuriy Zhulev, President, Russian Hemophilia Society
Yuriy Zhulev

President

Russian Hemophilia Society

Evgeniy Gordeev, Managing partner, Breffi
Evgeniy Gordeev

Managing partner

Breffi

Herman Inozemtsev, General Manager, PharmaSpace
Herman Inozemtsev

General Manager

PharmaSpace

Vladimir Egorov, General Manager, Proxima Research Russia
Vladimir Egorov

General Manager

Proxima Research Russia

Angela Simakova, Trade & Revenue Director, Sanofi in Eurasian region
Angela Simakova

Trade & Revenue Director

Sanofi in Eurasian region

Valery Eremenko, Partner, Head of Litigation Practice, Egorov Puginsky Afanasiev & Partners Law firm
Valery Eremenko

Partner, Head of Litigation Practice

Egorov Puginsky Afanasiev & Partners Law firm

Zakhar Golant, Head of Board, The Union of Pharmaceutical and Biomedical Clusters
Zakhar Golant

Head of Board

The Union of Pharmaceutical and Biomedical Clusters

Anna Ermolaeva, General Director, AlphaRM
Anna Ermolaeva

General Director

AlphaRM

Andrey Zelenin, Managing Partner, Lidings
Andrey Zelenin

Managing Partner

Lidings

Olga Pentegova, Deputy General Director for Legal Affairs,  Association of Russian Pharmaceutical Manufacturers
Olga Pentegova

Deputy General Director for Legal Affairs

Association of Russian Pharmaceutical Manufacturers

The Russian Pharmaceutical Forum goes VIRTUAL in 2020

Join us at the Russian Pharmaceutical Forum – a unique online gathering of key industry experts in the pharmaceutical sector!
In order to manage and comply with travel and social distancing restrictions, the Russian Pharmaceutical Forum will be hosted virtually on a FULLY INTERACTIVE ONLINE PLATFORM.

Stream sessions with leading pharma representatives and ask your questions to speakers in real time!

Meet new partners and digitally connect with key market players – via online chat, email and video calls!

Join the event directly from your laptop, tablet or smartphone – and save on time, money and travel!

Key topics at the Russian Pharmaceutical Forum 2020:

  • Analysis of the key regulatory changes affecting the pharmaceutical industry
  • COVID-19 pandemic: the response of the Russian pharmaceutical market
  • Drug pricing methodologies aimed at stimulating innovation
  • Drug labelling - success stories and implementation case studies
  • Public procurement optimisation and the formation of the Essential and Vital Drug List
  • How to ensure access to innovative treatments on the Russian market?
  • Evolution in producer - distributor - retailer dynamics
  • Sales trends, purchasing power and consumer demand forecasts
  • Developing the local active pharmaceutical substance production market
  • Medicine of the future: genomics, biotechnologies, personalised medicine

Digitalisation of the pharmaceutical industry and the healthcare system

  • Digital healthcare: telemedicine today and in the future
  • IT trends: best practices in using mobile technologies in the pharmaceutical industry
  • Data-centric marketing and data analytics for strategic planning
  • Smart technologies and innovation in drug manufacturing
  • New business models and online retail: consumer market transformation
  • Analytics, opportunities to share best practice and success stories from top pharma leaders

Pharma versus coronavirus: interviews with General Directors 

General Directors of the leading companies on the market have discussed with the Russian Pharmaceutical Forum the main challenges they are facing during the pandemic, and possible approaches to collaborating with the government on developing both a vaccine and treatments for COVID-19. 

The SARS-CoV-2 coronavirus pandemic has kicked the rate of development in the pharmaceutical industry into a new gear. At the early stages of the epidemic in Russia, the demand for medical masks, antiseptics and antivirals soared. A series of regulatory decisions followed, taken at an unprecedented speed, outlining a new set of rules for maximum retail prices and distance selling of medical products. 

The pharmaceutical industry is undergoing enormous change fuelled by a global crisis in healthcare. But pharma also has a key role to play in the search for ways out of the current situation. 

 

READ OUR PHRAMACEUTICAL BLOG>>

The most important pharmaceutical conference in Russia! Excellent opportunity to meet your key partners in one place

ALES SUSSINGER,

Commercial Director, KRKA FARMA

RUSSIAN PHARMACEUTICAL FORUM ATTENDEES INCLUDE:

Abbott Laboratories
AbbVie
Alfa Wassermann
Allergan
Almirall
Amgen
Angelini Francesco
Baxter
Bayer Pharma
Belupo
Berlin-Chemie
Besins Healthcare

Biogen Interntional
Bittner Pharma
Boehringer Ingelheim
Boiron
Bosnalijek
Bristol-Myers Squibb
EGIS
Eisai
Eli Lilly Vostok
Galderma
Glenmark Pharmaceuticals
Hikma Pharmaceuticals

Ipsen
KRKA Pharma
Lupin
Merck
Nanolek
Novo Nordisk
Petrovax Pharm
Ranbaxy
Reckitt Benckiser
Roche
Servier
Shreya Life Sciences

WHY TO ATTEND THE RUSSIAN PHARMACEUTICAL FORUM?

russianpharma 023

26 years in the market! Russia's longest-running pharmaceutical forum

russianpharma 018

The highest profile executive-level speakers and attendees

russianpharma 150

Unrivalled networking opportunities - meet key decision makers